In the United States, antimalarial drugs such as Plaquenil (hydrochloroquine) are used primarily for their anti-inflammatory effects in the treatment of auto-immune conditions (e.g., rheumatoid arthritis, lupus). It is estimated that approximately 3% of patients taking Plaquenil develop toxicity. The case presented involves a patient taking Plaquenil who did not show signs of Bull's eye maculopathy but who did exhibit abnormal ancillary test results.
Julie K. Torbit, OD, FAAO
Company: Indiana University School of Optometry
Release Date: Unknown
CE Credits: 1
CE Format: Online text/photos